Search for: "Mallinckrodt, Inc."
Results 21 - 40
of 85
Sort by Relevance
|
Sort by Date
19 Mar 2020, 9:55 pm
Praxair Distribution Inc. [read post]
4 Dec 2019, 9:15 am
Earlier this month, Mallinckrodt succeeded in its inter partes review (IPR) challenge against patent owner Biovie, Inc. [read post]
4 Dec 2019, 9:15 am
Earlier this month, Mallinckrodt succeeded in its inter partes review (IPR) challenge against patent owner Biovie, Inc. [read post]
3 Sep 2019, 2:03 am
” “Mallinckrodt did not develop a new use for an old drug that provides a therapeutic benefit. [read post]
28 Aug 2019, 7:27 pm
See Athena Diagnostics,Inc. v. [read post]
16 May 2019, 8:15 am
See Endo Pharms., Inc. v. [read post]
16 May 2019, 8:15 am
See Endo Pharms., Inc. v. [read post]
6 May 2019, 9:58 pm
Noonan -- Last Friday, the Federal Circuit affirmed a decision by the District Court that Defendants Actavis LLC and Teva Pharmaceuticals did not show by clear and convincing evidence that the claims asserted by Endo Pharmaceuticals Inc. and Mallinckrodt LLC were obvious, in Endo Pharmaceuticals Inc. v. [read post]
4 May 2019, 2:55 pm
Mallinckrodt then claimed thisrequirement in the ’779 patent. [read post]
25 Oct 2018, 6:00 am
” (In re Univar USA Inc., 311 S.W.3d 183, 186 (Tex. [read post]
20 Oct 2018, 1:00 pm
Baxter International Inc. acquired two hemostat and sealant products from Mallinckrodt plc. for $153 million. [read post]
27 Aug 2018, 10:01 pm
Mallinckrodt ARD Inc., No. 17 CV 50107, No. 18 CV 379 (N.D. [read post]
24 Aug 2018, 10:52 am
Mallinckrodt ARD Inc. [read post]
25 Jun 2018, 7:33 am
Lexmark, The Overruling of Mallinckrodt and The Future of Restraints on Alienation For Patented GoodsJames B. [read post]
21 May 2018, 9:46 pm
Mallinckrodt Hospital Products IP Ltd. [read post]
18 May 2018, 8:54 am
Mallinckrodt Hospital Products IP LTD., 2018 U.S. [read post]
18 May 2018, 4:37 am
Apple, Inc., 838 F.3d 1214, 1220 (Fed. [read post]
1 Dec 2017, 11:35 am
Paganini will complement OncoResponse, since OncoResponse has a strong focus on antibody cancer drugs and Paganini recently developed ONCR-201, a monoclonal antibody used in treating ovarian cancer.[29] Mallinckrodt PLC is expected to purchase Ocera Therapeutics Inc. in addition to its mid-stage hepatic encephalopathy, for about $42 million and to close in the fourth quarter of 2017. [read post]
30 Nov 2017, 8:59 pm
Counsel representing several Plaintiffs filed for consolidation of the actions of state, county, and municipal governments and other agencies against opiate manufacturers Purdue Pharma, Teva/Cephalon, Janssen, Endo, Actavis, and Mallinckrodt and distributors McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health, Inc. [read post]
17 Sep 2017, 6:00 am
Prometheus Laboratories, Inc., a standard affirmed by SCOTUS’ 2014 decision in Alice Corporation v. [read post]
